Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.0K
Overview
46.0K
Cross-reactivity00:42

Cross-reactivity

31.7K
Overview
31.7K
Active versus Passive Immunity01:31

Active versus Passive Immunity

5.3K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
5.3K
Development of Immunocompetence01:22

Development of Immunocompetence

503
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Incidence, Risk Factors, and Trends of Pharyngeal Cancer by Anatomical Sites: A Systematic Analysis of Cancer Registries.

Cancer reports (Hoboken, N.J.)·2026
Same author

Prevalence and correlates of e-cigarette use among older adults aged 60 years and over.

European geriatric medicine·2026
Same author

The mobile resistome in the water-soil-air nexus: horizontal gene transfer and environmental dissemination of antimicrobial resistance genes.

FEMS microbiology ecology·2026
Same author

Focusing on burden and capacity to support self-management of chronic health conditions: A pilot trial of care coordination in rural Australia: Implications for multimorbidity care in the Philippines.

Journal of multimorbidity and comorbidity·2026
Same author

Global Health Implications of US Exit From WHO and Suspension of Aid.

Public health challenges·2026
Same author

From Sanitizer Use to Safe Practice: Pandemic Insights for Health Communication.

Workplace health & safety·2026

Related Experiment Video

Updated: Oct 11, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.9K

Can Africa achieve herd immunity?

Don Eliseo Lucero-Prisno1,2, Isaac Olushola Ogunkola3, Ekpereonne Babatunde Esu3

  • 1Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK. donprisno@hotmail.com.

Global Health Research and Policy
|December 2, 2021
PubMed
Summary

Achieving herd immunity in Africa requires vaccinating a significant portion of the population against COVID-19. Challenges like vaccine distribution and hesitancy must be addressed for equitable global immunity.

Keywords:
AfricaCOVID-19Herd immunityVaccine

More Related Videos

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

7.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.8K

Related Experiment Videos

Last Updated: Oct 11, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.9K
Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

7.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.8K

Area of Science:

  • Epidemiology
  • Public Health
  • Vaccinology

Background:

  • Herd immunity, or population immunity, protects populations from infectious diseases through widespread immunity from vaccination or prior infection.
  • The COVID-19 pandemic highlighted the critical need for herd immunity, with global vaccination efforts showing significant disparities, particularly in Africa.

Purpose of the Study:

  • To forecast the vaccination numbers needed to achieve herd immunity in 13 priority African countries.
  • To identify key challenges and propose strategies for equitable vaccine distribution and integration in Africa.

Main Methods:

  • The study likely involved epidemiological modeling to estimate reproduction numbers (R0) and required vaccination thresholds.
  • Analysis of vaccine distribution infrastructure, cold chain capacity, and vaccine hesitancy factors in African nations.

Main Results:

  • Over one billion people vaccinated globally, but Africa accounts for only 2% of vaccinations.
  • Weaknesses in vaccine delivery, distribution, and cold chain infrastructure identified as major barriers.
  • Vaccine hesitancy poses a significant risk to achieving herd immunity in Africa.

Conclusions:

  • Equitable vaccine distribution is essential for global herd immunity, ensuring African countries are not excluded.
  • Strengthening healthcare services, community sensitization, and stakeholder commitment are crucial for successful COVID-19 vaccine integration and achieving herd immunity in Africa.